CXCR4 and neoplasm: ,24 The availability of these syngeneic WT and TgMISIIR-TAg-Low mice allowed us to compare the in vivo effects of TAg expressed as a neoantigen and tumor/self-antigen, respectively, on generation of TAg-specific CD8+ T cells and OV-CXCR4-A treatment efficacy.